Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 10
Submit an article Journal homepage
386
Views
18
CrossRef citations to date
0
Altmetric
Letters to the Editor

Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis

Lurdes ZamoraICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, SpainCorrespondence[email protected]
,
Blanca XicoyICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
,
Marta CabezónICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
,
Cristalina FernandezICO Girona – Hospital Josep Trueta, Girona, Spain
,
Silvia MarcéICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
,
Patricia VelezICO Hospitalet – Hospital Duran i Reynals, Barcelona, Spain
,
Marisol XandriICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
,
David GallardoICO Girona – Hospital Josep Trueta, Girona, Spain
,
Fuensanta MilláICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
,
Evarist FeliuICO Badalona – Hospital Germans Trias i Pujol, Universitat Auntònoma de Barcelona, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
&
Concepción BoquéICO Hospitalet – Hospital Duran i Reynals, Barcelona, Spain
 show all
Pages 2973-2974 | Received 25 Nov 2014, Accepted 31 Jan 2015, Published online: 11 Mar 2015
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis." Leukemia & Lymphoma, 56(10), pp. 2973–2974

Acknowledgments

The authors would like to thank Diana Dominguez for her excellent technical assistance, to the grant 2014 SGR225 (GRE), Generalitat de Catalunya, Obra Social La Caixa and to Fundaci Josep Carreras contra la Leucemia.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.